The variety of organoids that can be developed in vitro is enabling major advances. Depending on the type of tissues and the research goals, these small 3D cell-based structures that mimic real tissue ...

Cancer remains a leading cause of morbidity and mortality, although cancer survivorship has increased impressively in the past decades. Patients with cancer often face cardiovascular complications, ...

For many families, the most shocking part of a cancer journey is not the tumour itself, but the steady wasting that follows — loss of appetite, falling weight, thinning muscles, and the feeling that ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Ellen Lee Ellen Lee is a writer focused on parenting and health gear. She has ...

With cachexia, the muscles in your body will waste away regardless of how much you eat. The condition causes severe weight loss. (Photo Credit: Dr P. Marazzi/Science Source) Cachexia (aka “wasting ...

Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...

A Terasaki Institute study shows vagus nerve modulation can halt cancer-associated cachexia (CAC), a wasting syndrome causing over one-third of cancer deaths. By restoring brain-liver communication, ...

Los Angeles, CA – August 14, 2025 – The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a ...

DelveInsight's 'Cancer Cachexia Pipeline Insight 2025' report provides comprehensive global coverage of pipeline cancer cachexia therapies in various stages of clinical development, major ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...